Divergence from osteoporosis screening guidelines in older breast cancer patients treated with anti-estrogen therapy: A population-based cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Divergence from osteoporosis screening guidelines in older breast cancer patients treated with anti-estrogen therapy: A population-based cohort study

Published:2018-11 Issue: Volume:116 Page:94-102
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Henault David,Westley Tracy,Dumitra Sinziana,Chang Sue-Ling,Kremer Richard,Tamblyn Robyn,Mayo Nancy,Meguerditchian Ari N.^ORCID

Funder

Canadian Institutes of Health Research

Canadian Cancer Society Research Institute

Quebec Health Research Fund

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference45 articles.

1. Cancer treatment and survivorship statistics, 2014;DeSantis;CA Cancer J. Clin.,2014

2. Survivorship: adult cancer survivors;Ganz;Prim. Care,2009

3. Screening and management of osteoporosis in breast cancer patients on aromatase inhibitors;Gibson;J. Oncol. Pharm. Pract.,2008

4. Adjuvant endocrine therapy for women with hormone receptor–positive breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update;Burstein;J. Clin. Oncol.,2014

5. Early Breast Cancer Trialists' Collaborative G: Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet 386:1341–1352.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. National reimbursement databases: Use and limitations for rheumatologic studies;Joint Bone Spine;2022-10

2. Bases de données nationales de remboursement : utilisation et limites dans le contexte des études de rhumatologie;Revue du Rhumatisme;2022-10

3. Protective effect of resveratrol on estrogen deficiency-induced osteoporosis though attenuating NADPH oxidase 4/nuclear factor kappa B pathway by increasing miR-92b-3p expression;International Journal of Immunopathology and Pharmacology;2020-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3